---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-26-000068"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2026-05-01T23:59:59+00:00"
generated_at: "2026-05-15T00:17:47.759407+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioRestorative Therapies approves 2025 executive bonuses; CEO bonus $300K, VP $287.5K, CFO $140K

## Summary
- CEO Lance Alstodt awarded $300K cash bonus and $1.5M in option awards; total 2025 compensation $2.4M.
- VP Francisco Silva gets $287.5K bonus plus $1.47M in options; total 2025 comp $2.3M.
- CFO Robert Kristal awarded $140K bonus and $318K in options; total 2025 comp $801,750.
- All bonuses are discretionary for 2025 services, payable in 2026; total compensation up significantly from 2024.

## SEC filing metadata
- accession: 0001021771-26-000068
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2026-05-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000068/0001021771-26-000068-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177126000068/brtx-20260501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-26-000068
- JSON: https://secwatch.observer/filing/0001021771-26-000068.json
- Plain text: https://secwatch.observer/filing/0001021771-26-000068.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.